Management of ventilator-associated pneumonia: Need for a personalized approach

Expert Review of Anti-infective Therapy
Eshwara Vandana Kalwaje, Jordi Rello

Abstract

Optimizing management of ventilator-associated pneumonia (VAP) should focus on the accurate identification of true lung infection, determination of the etiological agent, and early institution of adequate empirical therapy and de-escalation. Local adaptation of the standard guidelines leads to favorable outcome in the management of VAP Areas covered: In this review, we present the concepts of early adequate therapy and the key considerations such as patient characters, clinical and etiological diagnosis, and assessment of patients for de-escalation that favor optimization of therapy. We highlight the issues that need a personalized approach in the management of VAP emphasizing on various patient categories for reassessment and tailoring the therapy. Expert commentary: Rapid diagnostic techniques and non-invasive metabolomics will identify phenotypes which will shift the traditional paradigm based on conventional cultures. A personalized approach taking into account baseline resistance epidemiology, underlying disease (and comorbidities), duration of hospitalization, and prior antimicrobial exposure should guide targeted therapy.

References

Sep 1, 1990·The American Review of Respiratory Disease·A TorresR Rodriguez-Roisin
Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·A TorresR Rodriguez-Roisin
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J RelloR Rodriguez-Roisin
Aug 1, 1994·American Journal of Respiratory and Critical Care Medicine·M S NiedermanW Summer
Jul 1, 1996·American Journal of Respiratory and Critical Care Medicine·J RelloJ Vallés
Nov 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J RelloM S Niederman
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·J M Sanchez-NietoM Niederman
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·J RelloP Coll
Dec 1, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M PujolF Gudiol
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·P J DennesenM J Bonten
Oct 5, 2001·American Journal of Infection Control·M W MahR M Bannatyne
Dec 3, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kwan Kew LaiSally A Fontecchio
Dec 3, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Zeina A KanafaniSouha S Kanj
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc J M BontenJesse B Hall
Jan 13, 2005·Critical Care Medicine·Andrew F ShorrMarin H Kollef
Sep 16, 2005·Nursing in Critical Care·Eddie CrundenBarbara Bray
Oct 11, 2005·Critical Care Medicine·Nasia SafdarSanjay Saint
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Valerie AloushYehuda Carmeli
Jan 3, 2006·The European Respiratory Journal·C M LunaUNKNOWN Grupo Argentino de Estudio de la Neumonía Asociada al Respirador group
Mar 14, 2007·The Journal of Hospital Infection·P J Z TeixeiraJ M G Fachel
Jun 15, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David J WeberMichael S Niederman
Jun 22, 2007·Critical Care : the Official Journal of the Critical Care Forum·Thiago Lisboa, Jordi Rello
Oct 27, 2007·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·João Manoel da SilvaJoão Silva de Mendonça
Dec 7, 2007·Annals of Internal Medicine·Michael Klompas, Richard Platt
Mar 5, 2008·Current Opinion in Infectious Diseases·Thiago Lisboa, Jordi Rello
Mar 25, 2008·Journal of Critical Care·John G MuscedereDaren K Heyland
Aug 30, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D E GhannamA Safdar
Feb 28, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Allan J WalkeyMartin Joyce-Brady
Jun 27, 2009·Intensive Care Medicine·Javier HortalPatricia Muñoz
Feb 24, 2010·American Journal of Infection Control·Victor D RosenthalUNKNOWN INICC Members

❮ Previous
Next ❯

Citations

Feb 20, 2019·Frontiers in Pharmacology·Qingqing LiuJun Lyu
Jan 27, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Despoina KoulentiJordi Rello
Apr 20, 2019·Frontiers in Pharmacology·Xinming XieManxiang Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.